Metsera's obesity drug shows promising weight loss in mid-stage trials
Metsera Inc(US:MTSR) Reuters·2025-09-29 20:11Metsera said on Monday that its experimental obesity drug showed significant weight loss and favorable tolerability in mid-stage studies. ...